Transfusion Medicine Reviews
Volume 23, Issue 1 , Pages 13-24 , January 2009

Animal Models of Transfusion-Related Acute Lung Injury

References 

  1. Barnard RD. Indiscriminate transfusion: A critique of case reports illustrating hypersensitivity reactions. N Y State J Med. 1951;51:2399–2402
  2. Brittingham T, Chaplin H. Febrile transfusion reactions caused by sensitivity to donor leukocytes and platelets. JAMA. 1957;165:819–825
  3. Finlay HE, Cassorla L, Feiner J, et al. Designing and testing a computer-based screening system for transfusion-related acute lung injury. Am J Clin Pathol. 2005;124:601–609
  4. Kopko PM, Holland PV. Transfusion-related acute lung injury. Br J Haematol. 1999;105:322–329
  5. Kopko PM, Marshall CS, MacKenzie MR, et al. Transfusion-related acute lung injury: Report of a clinical look-back investigation. JAMA. 2002;287:1968–1971
  6. Finlay-Morreale HE, Louie C, Toy P. Computer-generated automatic alerts of respiratory distress after blood transfusion. J Am Med Inform Assoc. 2008;15:383–385
  7. Goldman M, Webert KE, Arnold DM, et al. Proceedings of a consensus conference: Towards an understanding of TRALI. Transfus Med Rev. 2005;19:2–31
  8. Silliman CC, Ambruso DR, Boshkov LK. Transfusion-related acute lung injury. Blood. 2005;105:2266–2273
  9. Kleinman S, Caulfield T, Chan P, et al. Toward an understanding of transfusion-related acute lung injury: Statement of a consensus panel. Transfusion. 2004;44:1774–1789
  10. Cherry T, Steciuk M, Reddy VV, et al. Transfusion-related acute lung injury: Past, present, and future. Am J Clin Pathol. 2008;129:287–297
  11. Holness L, Knippen MA, Simmons L, et al. Fatalities caused by TRALI. Transfus Med Rev. 2004;18:184–188
  12. Sheppard CA, Logdberg LE, Zimring JC, et al. Transfusion-related acute lung injury. Hematol Oncol Clin North Am. 2007;21:163–176
  13. Philipps E, Fleischner FG. Pulomonary edema in the course of a blood transfusion without overloading the circulation. Diseases of the Chest. 1966;50:619–623
  14. Thompson JS, Severson CD, Parmely MJ, et al. Pulmonary “hypersensitivity” reactions induced by transfusion of non–HL-A leukoagglutinins. N Engl J Med. 1971;284:1120–1125
  15. Ward HN. Pulmonary infiltrates associated with leukoagglutinin transfusion reactions. Ann Intern Med. 1970;73:689–694
  16. Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion. 1985;25:573–577
  17. Curtis BR, McFarland JG. Mechanisms of transfusion-related acute lung injury (TRALI): Anti-leukocyte antibodies. Crit Care Med. 2006;34:S118–S123
  18. Kopko PM. Leukocyte antibodies and biologically active mediators in the pathogenesis of transfusion-related acute lung injury. Curr Hematol Rep. 2004;3:456–461
  19. Silliman CC, Boshkov LK, Mehdizadehkashi Z, et al. Transfusion-related acute lung injury: Epidemiology and a prospective analysis of etiologic factors. Blood. 2003;101:454–462
  20. Silliman CC, Bjornsen AJ, Wyman TH, et al. Plasma and lipids from stored platelets cause acute lung injury in an animal model. Transfusion. 2003;43:633–640
  21. Bux J, Sachs UJ. The pathogenesis of transfusion-related acute lung injury (TRALI). Br J Haematol. 2007;136:788–799
  22. Silliman CC. The two-event model of transfusion-related acute lung injury. Crit Care Med. 2006;34:S124–S131
  23. Kopko PM, Popovsky MA, MacKenzie MR, et al. HLA class II antibodies in transfusion-related acute lung injury. Transfusion. 2001;41:1244–1248
  24. Kopko PM, Paglieroni TG, Popovsky MA, et al. TRALI: Correlation of antigen-antibody and monocyte activation in donor-recipient pairs. Transfusion. 2003;43:177–184
  25. Nishimura M, Hashimoto S, Satake M, et al. Interference with TRALI-causing anti-HLA DR alloantibody induction of human pulmonary microvascular endothelial cell injury by purified soluble HLA DR. Vox Sang. 2007;93:78–82
  26. Nishimura M, Hashimoto S, Takanashi M, et al. Role of anti-human leucocyte antigen class II alloantibody and monocytes in development of transfusion-related acute lung injury. Transfus Med. 2007;17:129–134
  27. Wakamoto S, Fujihara M, Sakagawa H, et al. Endothelial permeability is increased by the supernatant of peripheral blood mononuclear cells stimulated with HLA Class II antibody. Transfusion. 2008;48:2060–2068
  28. Middelburg RA, van Stein D, Briet E, et al. The role of donor antibodies in the pathogenesis of transfusion-related acute lung injury: A systematic review. Transfusion. 2008;48:2167–2176
  29. Bux J, Becker F, Seeger W, et al. Transfusion-related acute lung injury due to HLA-A2–specific antibodies in recipient and NB1-specific antibodies in donor blood. Br J Haematol. 1996;93:707–713
  30. Popovsky MA, Chaplin HC, Moore SB. Transfusion-related acute lung injury: A neglected, serious complication of hemotherapy. Transfusion. 1992;32:589–592
  31. Wyman TH, Bjornsen AJ, Elzi DJ, et al. A two-insult in vitro model of PMN-mediated pulmonary endothelial damage: Requirements for adherence and chemokine release. Am J Physiol Cell Physiol. 2002;283:C1592–C1603
  32. Khan SY, Kelher MR, Heal JM, et al. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood. 2006;108:2455–2462
  33. Silliman CC, Curtis BR, Kopko PM, et al. Donor antibodies to HNA-3a implicated in TRALI reactions prime neutrophils and cause PMN-mediated damage to human pulmonary microvascular endothelial cells in a two-event in vitro model. Blood. 2007;109:1752–1755
  34. Seeger W, Schneider U, Kreusler B, et al. Reproduction of transfusion-related acute lung injury in an ex vivo lung model. Blood. 1990;76:1438–1444
  35. Sachs UJ, Hattar K, Weissmann N, et al. Antibody-induced neutrophil activation as a trigger for transfusion-related acute lung injury in an ex vivo rat lung model. Blood. 2006;107:1217–1219
  36. Silliman CC, Voelkel NF, Allard JD, et al. Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest. 1998;101:1458–1467
  37. Looney MR, Matthay MA. Animal models of transfusion-related acute lung injury. Crit Care Med. 2006;34:S132–S136
  38. Vlaar AP, Zweers MM, Schultz MJ, et al. Developing specific therapeutic strategies for transfusion-related acute lung injury. An overview of potentially useful animal models. Cardiovasc Hematol Agents Med Chem. 2007;5:319–326
  39. Ashbaugh DG, Bigelow DB, Petty TL, et al. Acute respiratory distress in adults. Lancet. 1967;2:319–323
  40. Kabir K, Gelinas JP, Chen M, et al. Characterization of a murine model of endotoxin-induced acute lung injury. Shock. 2002;17:300–303
  41. Ritter C, da Cunha AA, Echer IC, et al. Effects of N-acetylcysteine plus deferoxamine in lipopolysaccharide-induced acute lung injury in the rat. Crit Care Med. 2006;34:471–477
  42. Rabinovici R, Bugelski PJ, Esser KM, et al. ARDS-like lung injury produced by endotoxin in platelet-activating factor-primed rats. J Appl Physiol. 1993;74:1791–1802
  43. Salzer WL, McCall CE. Primed stimulation of isolated perfused rabbit lung by endotoxin and platelet activating factor induces enhanced production of thromboxane and lung injury. J Clin Invest. 1990;85:1135–1443
  44. Hicks W, Susskind B, Strait R, et al. Pathogenesis of transfusion related acute lung injury (TRALI) in an in vivo murine model. Hum Immunol. 2004;65:S10;[abstr]
  45. Hicks WA, Susskind B, Strait R, et al. In vivo murine model of transfusion-related acute lung injury. Transfusion. 2004;44:23A;[abstr]
  46. Strait R, Susskind B, Finkelman F. Murine TRALI: 1-Hit vs. 2-Hit model. Hum Immunol. 2005;66:S18;[abstr]
  47. Strait RT, Hicks W, Susskind BM, et al. Murine model of transfusion related acute lung injury (TRALI) due to anti-MHC. Hum Immunol. 2003;64:S43;[abstr]
  48. Strait RT, Hicks W, Woodrich T, et al. One- and two-hit mouse models of transfusion-related acute lung injury (TRALI). FASEB J. 2005;19:A1508
  49. Finkelman F: 2005 (pers commun).
  50. Looney MR, Su X, Van Ziffle JA, et al. Neutrophils and their Fc gamma receptors are essential in a mouse model of transfusion-related acute lung injury. J Clin Invest. 2006;116:1615–1623
  51. Looney MR, Barbeau R, Barczak A, et al. Microarray analysis of a mouse model of transfusion-related acute lung injury (TRALI) reveals prominent increased expression of neutrophil-derived chemokines. FASEB J. 2007;21:894.9;[abstr]
  52. Looney MR, Lowell CA, Matthay MA. Platelets are sequestered in the lungs of experimental transfusion-related acute lung injury (TRALI) and platelet depletion protects mice from TRALI. Thorax. 2007;62:A62;[abstr]
  53. Strait R: 2007 (pers commun).
  54. Silliman CC, Mansuno T, Kelher M, et al. An in vivo two-event model of transfusion-related acute lung injury. Transfusion. 2006;46:93A;[abstr]
  55. Silliman CC, Kehler M, Mansuno T, et al. A two-event in vivo model of transfusion-related acute lung injury. Blood. 2006;108:10a;[abstr]

PII: S0887-7963(08)00070-9

doi: 10.1016/j.tmrv.2008.09.002

Transfusion Medicine Reviews
Volume 23, Issue 1 , Pages 13-24 , January 2009

Article Tools

* Image Usage & Resolution